Underrecognition of migraine‐related stigmatizing attitudes and social burden: Results of the OVERCOME Japan study

Author:

Igarashi Hisaka1,Komori Mika2ORCID,Ueda Kaname2,Zagar Anthony J.3,Jaffe Dena H.4ORCID,Matsumori Yasuhiko5,Takeshima Takao6,Hirata Koichi7

Affiliation:

1. Fujitsu Clinic Kawasaki Japan

2. Japan Drug Development and Medical Affairs Eli Lilly Japan K.K. Kobe Japan

3. Real World and Access Analytics Eli Lilly and Company Indianapolis Indiana USA

4. Real World Evidence Cerner Enviza, an Oracle Company (formerly Kantar Health) Jerusalem Israel

5. Sendai Headache and Neurology Clinic Sendai Japan

6. Department of Neurology, Headache Center Tominaga Hospital Osaka Japan

7. Department of Neurology Dokkyo Medical University Mibu Japan

Abstract

AbstractIntroductionMigraine‐related stigma (MiRS) and social burden is increasingly recognized. We assessed perspectives and attitudes toward migraine in people with and without migraine in Japan.MethodsOVERCOME (Japan) was a cross‐sectional, population‐based web survey of people with and without migraine (July−September 2020). People with migraine were individuals who met the modified International Classification of Headache Disorders criteria or had self‐reported physician‐diagnosed migraine. People without migraine were selected per quota sampling to represent the Japanese adult population. People with migraine reported their experiences on stigma and social burden and answered how frequently they experienced stigma using the MiRS questionnaire. Associations between MiRS and disability and MiRS and interictal burden were examined using the migraine disability assessment and Migraine Interictal Burden Scale‐4. People without migraine reported their experiences and attitudes toward people with migraine by answering an 11‐item attitudinal migraine questionnaire.ResultsA total of 17,071 and 2008 people with and without migraine, respectively, completed the survey. Overall, 11,228 (65.8%) respondents with migraine reported that they have never experienced stigma or burden; however, of the 12,383 employed respondents, 5841 (47.2%) reported that their current employers are not “extremely” or “very” understanding about their conditions. Moreover, ∼30%−40% of respondents “sometimes,” “often,” or “very often” hid their migraine from others. The proportion of respondents who experienced stigma often or very often, as assessed by MiRS, was 16.5%; this increased with the increasing number of monthly migraine headache days. The proportion of respondents with moderate‐to‐severe disability and interictal burden increased with increasing stigma. Among respondents without migraine, the proportion holding a stigmatizing attitude toward those with migraine was low (<15%); ∼80% had never experienced work‐ or family‐related stigma or burden.ConclusionMiRS and burden exist but may be hidden and underrecognized in Japan. Disease awareness and education may be important to prevent and reduce stigma and burden.

Funder

Eli Lilly and Company

Publisher

Wiley

Reference30 articles.

1. Development and validation of the Migraine Interictal Burden Scale (MIBS): A self‐administered instrument for measuring the burden of migraine between attacks;Buse D. C.;Neurology,2007

2. Assessing and Managing All Aspects of Migraine: Migraine Attacks, Migraine-Related Functional Impairment, Common Comorbidities, and Quality of Life

3. Vancouver Declaration II on Global Headache Patient Advocacy 2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3